Showing results (951-960 of 1,154) with videos related to

Sort By:
Pageof 116
Bioscience Trends|February 2, 2025
Development and validation of a nomogram model for predicting immune-mediated hepatitis in cancer patients treated with immune checkpoint inhibitorsQianjie Xu, Xiaosheng Li, Yuliang Yuan, et al.
Bioscience Trends|December 8, 2024
Machine learning-based prognostic prediction and surgical guidance for intrahepatic cholangiocarcinomaLong Huang, Jianbo Li, Shuncang Zhu, et al.
Bioscience Trends|December 4, 2024
The APP Score: A simple serum biomarker model to enhance prognostic prediction in hepatocellular carcinomaJinyu Zhang, Qionglan Wu, Jinhua Zeng, et al.
Bioscience Trends|December 25, 2024
Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition)Haowen Tang, Wenwen Zhang, Junning Cao, et al.
Bioscience Trends|December 8, 2024
First-line systemic therapy and sequencing options in advanced biliary tract cancer: A systematic review and network meta-analysisRanning Xu, Jian Zhou, Jian Yang, et al.
Bioscience Trends|October 16, 2024
FNDC5/Irisin mitigates high glucose-induced neurotoxicity in HT22 cell via ferroptosisLingling Yang, Xiaohan Zhou, Tian Heng, et al.
Bioscience Trends|October 14, 2024
mFOLFOX-HAIC+lenvatinib+PD-1 inhibitors versus GC/GS/GEMOX chemotherapy as a first line therapy for advanced biliary tract cancer: A single-center retrospective cohort studyZhipeng Sun, Hai Xu, Lei Yang, et al.
Bioscience Trends|September 23, 2024
How spousal cognitive functioning affects the level of depression in middle-aged and older adults: An instrumental variable study based on CHARLS in ChinaZheng Wang, Ting Li, Jingbin Zhang, et al.
Bioscience Trends|June 26, 2024
Suppression of STK39 weakens the MASLD/MASH process by protecting the intestinal barrierQing Xu, Fei Liu, Zhenru Wu, et al.
Bioscience Trends|January 22, 2023
RNA-binding proteins in metabolic-associated fatty liver disease (MAFLD): From mechanism to therapyJiawei Xu, Xingyu Liu, Shuqin Wu, et al.
Pageof 116